Drugdiscovery >> Pharmaceutical Companies >> News
4766
Views
title
AbbVie’s cystic fibrosis deal - drugdiscovery.com


AbbVie enters into collaboration with Dutch drug developer Galapagos NV with the aim to study treatments for cystic fibrosis. The deal could be worth more than $405 million to Galapagos.
Read More >>


Tags: AbbVie, Galapagos, cystic fibrosis, deal - September 25, 2013
Related Articles
4804
Views
Celgene, PharmAkea partnership Celgene, PharmAkea partnership
Celgene has entered into a collaboration with a biotech upstart PharmAkea Therapeutics, signing a three-deal to collaborate on cancer and cystic fibrosis drug development. Read More >>

Tags: Celgene, PharmAkea Therapeutics, partnership, collaboration, cancer, cystic fibrosis, CF, drug development

5211
Views
Sanofi - Pozen deal Sanofi - Pozen deal
The two companies agreed that Sanofi handles U.S. marketing of Pozen’s experimental cardiovascular drugs PA8140 and PA32540, intended as an alternative to aspirin as a secondary treatment for the pr Read More >>

Tags: Sanofi, Pozen, deal, agreement, US marketing, experimental cardiovascular drugs, PA8140, PA32540

6422
Views
Merck, AstraZeneca ovarian cancer drug deal Merck, AstraZeneca ovarian cancer drug deal
AstraZeneca will take over from Merck the clinical development of a potential ovarian cancer treatment , MK-1775, which is in mid-stage clinical testing as a possible oral treatment for certain form Read More >>

Tags: Merck, AstraZeneca, deal, ovarian cancer, drug, development

4496
Views
Bayer and Compugen signed a deal Bayer and Compugen signed a deal
The collaboration centres around the development of antibody-based therapeutics for cancer immunotherapy. Read More >>

Tags: collaboration, Bayer, Compugen, cancer immunotherapy

1638
Views
Actavis buys Warner Chilcott Actavis buys Warner Chilcott
Shareholders of Actavis and Ireland-based Warner Chilcott have approved the deal which will make the new Actavis the third-largest specialty pharmaceutical company in the U.S. market. The deal is ex Read More >>

Tags: Actavis, Warner Chilcott, deal, purchase

2190
Views
Otsuka to buy Astex Otsuka to buy Astex
Otsuka Pharmaceutical Co. will buy Astex Pharmaceuticals Inc. for about $804.1 million in cash. Otsuka expects this purchase to boost its research capabilities and pipeline of products for neuroscienc Read More >>

Tags: Otsuka, Astex, purchase, deal, Otsuka Pharmaceutical, Astex Pharmaceuticals

2961
Views
Amgen will buy Onyx Pharmaceuticals Amgen will buy Onyx Pharmaceuticals
The biotech giant Amgen will buy cancer drug maker Onyx Pharmaceuticals for $10.4 billion. The purchase is expected to close early in the fourth quarter. Amgen gets this way three approved cancer tre Read More >>

Tags: Amgen, Onyx Pharmaceuticals, purchase, buy, deal

1636
Views
Pharmaceutical companies team up to deal with Pharmaceutical companies team up to deal with "big data challenge"
Cancer Research UK says it teams up with other oharmaceutical and technical companies to solve the big data problems. huge amounts of DATA received from studies is going to be analyzed now. Read More >>

Tags: DATA, analisys, study, big data, cancer research, big data cancer research, Cancer research UK

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013